E7 TCR: 15 Clinical Trials, Page 1 of 2

A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer

Condition(s):Papillomavirus Infections; Oropharyngeal NeoplasmsLast Updated:September 22, 2020Withdrawn

E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial Neoplasia

Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:July 15, 2020Withdrawn

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Condition(s):HPV-Associated Cervical Carcinoma; HPV-Related Carcinoma; HPV-Related Malignancy; HPV Positive Oropharyngeal Squamous Cell Carcinoma; HPV-Related Adenocarcinoma; HPV-Related Adenosquamous Carcinoma; HPV-Related Squamous Cell Carcinoma; HPV-Related Anal Squamous Cell Carcinoma; HPV-Related Penile Squamous Cell Carcinoma; HPV-Related Vulvar Squamous Cell Carcinoma; HPV-Related Endocervical Adenocarcinoma; Cervical Cancer; Oropharynx Cancer; Anal Cancer; Vulvar Cancer; Penile Cancer; Vaginal CancerLast Updated:March 28, 2023Suspended

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Condition(s):Cervical Cancer; Throat Cancer; Oropharynx Cancer; Anal Cancer; Vulva Cancer; Vaginal Cancer; Penile Cancer; Metastatic Cancer; HPV-Related Malignancy; HPV-Related Carcinoma; HPV-Related Cervical Carcinoma; HPV-Related Squamous Cell Carcinoma; HPV-Related Adenocarcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma; HPV-Associated Vaginal Adenocarcinoma; HPV-Related Adenosquamous Carcinoma; HPV-Related Endocervical Adenocarcinoma; HPV-Related Anal Squamous Cell Carcinoma; HPV-Related Penile Squamous Cell Carcinoma; HPV-Related Vulvar Squamous Cell Carcinoma; HPV Positive Rectal Squamous Cell CarcinomaLast Updated:March 27, 2023Recruiting

E7 TCR T Cell Induction Immunotherapy for Stage IIB-IVA Cervical Cancer

Condition(s):Uterine Cervical NeoplasmsLast Updated:December 15, 2021Terminated

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Condition(s):Papillomavirus Infections; Cervical Intraepithelial Neoplasia; Carcinoma In Situ; Vulvar Neoplasms; Vulvar DiseasesLast Updated:September 6, 2023Recruiting

E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer

Condition(s):Papillomavirus Infections; Oropharyngeal NeoplasmsLast Updated:February 24, 2022Terminated

Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Condition(s):Squamous Lntraepithelial Lesions of Vulva; Neoplasms, Squamous Cell; Vulvar HSILLast Updated:April 13, 2021Terminated

Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

Condition(s):Human Papillomavirus (HPV) 16+ Relapsed/Refractory CancerLast Updated:May 25, 2022Terminated

Dose Optimization Trial of CD19 Redirected Autologous T Cells

Condition(s):Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLLLast Updated:June 22, 2023Completed

1 2 »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.